Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 4, 2006, Pages

  Ohashi, Shinya ^a   Nishio, Akiyoshi ^a   Nakamura, Hajime ^b   Kido, Masahiro ^a   Ueno, Satoru ^a   Uza, Norimitsu ^a   Inoue, Satoko ^a   Kitamura, Hiroshi ^a   Kiriya, Keiichi ^a   Asada, Masanori ^a   Tamaki, Hiroyuki ^a   Matsuura, Minoru ^a   Kawasaki, Kimio ^a   Fukui, Toshiro ^a   Watanabe, Norihiko ^a   Nakase, Hiroshi ^a   Yodoi, Junji ^a   Okazaki, Kazuichi ^c   Chiba, Tsutomu ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute pancreatitis; Antioxidant; Reactive oxygen species; Redox regulation; Thioredoxin 1

Indexed keywords

CERULETIDE; CHEMOATTRACTANT; CHEMOKINE; CHOLECYSTOKININ DERIVATIVE; CYTOKINE; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; RECOMBINANT PROTEIN; THIOREDOXIN; THIOREDOXIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; CYTOPLASM; DEGRADATION; DISEASE SEVERITY; DOSE RESPONSE; ENZYME ACTIVITY; HOST RESISTANCE; KERATINOCYTE; MALE; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ACUTE DISEASE; ANIMALS; CYTOKINES; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; OXIDATION-REDUCTION; PANCREATITIS, ACUTE NECROTIZING; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; THIOREDOXIN; TREATMENT OUTCOME;

EID: 33645799953     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00425.2005     Document Type: Article

References (54)

1. Altavilla D, Famulari C, Passaniti M, Galeano M, Macri A, Seminara P, Minutoli L, Marini H, Calo M, Venuti FS, Esposito M, and Squadrito F. Attenuated cerulein-induced pancreatitis in nuclear factor-kappaB-deficient mice. Lab Invest 83: 1723-1732, 2003.
2. Bhatia M, Brady M, Kang YK, Costello E, Newton DJ, Christmas SE, Neoptolemos JP, and Slavin J. MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation. Am J Physiol Gastrointest Liver Physiol 282: G77-G85, 2002.
3. Bhatia M, Ramnath RD, Chevali L, and Guglielmotti A. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 288: G1259-G1265, 2005.
4. Bizzarri C, Holmgren A, Pekkari K, Chang G, Colotta F, Ghezzi P, and Bertini R. Requirements for the different cysteines in the chemotactic and desensitizing activity of human thioredoxin. Antioxid Redox Signal 7: 1189-1194, 2005.
5. Blanchard JA, 2nd Barve S, Joshi-Barve S, Talwalker R, and Gates LK Jr. Antioxidants inhibit cytokine production and suppress NF-kappaB activation in CAPAN-1 and CAPAN-2 cell lines. Dig Dis Sci 46: 2768-2772, 2001.
6. Bradley PP, Priebat DA, Christensen RD, and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209, 1982.
7. Chae HZ, Robison K, Poole LB, Church G, Storz G, and Rhee SG. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci USA 91: 7017-7021, 1994.
8. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Centorrino T, Ciccolo A, Van de Loo FA, Britti D, Caputi AP, and Thiemermann C. Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock 17: 416-422, 2002.
9. Dabrowski A, Konturek SJ, Konturek JW, and Gabryelewicz A. Role of oxidative stress in the pathogenesis of caerulein-induced acute pancreatitis. Eur J Pharmacol 377: 1-11, 1999.
10. Das KC and Das CK. Thioredoxin, a singlet oxygen quencher and hydroxyl radical scavenger: redox independent functions. Biochem Biophys Res Commun 277: 443-447, 2000.
11. DiDonato JA, Mercurio F, and Karin M. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol Cell Biol 15: 1302-1311, 1995.
12. Ding SP, Li JC, and Jin C. A mouse model of severe acute pancreatitis induced with caerulein and lipopolysaccharide. World J Gastroenterol 9: 584-589, 2003.
13. Gomez-Cambronero LG, Sabater L, Pereda J, Cassinello N, Camps B, Vina J, and Sastre J. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Curr Drug Targets Inflamm Allergy 1: 393-403, 2002.
14. Gray KD, Simovic MO, Chapman WC, Blackwell TS, Christman JW, May AK, Parman KS, and Stain SC. Endotoxin potentiates lung injury in cerulein-induced pancreatitis. Am J Surg 186: 526-530, 2003.
15. Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, and Pandol SJ. Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol Gastrointest Liver Physiol 275: G1402-G1414, 1998.
16. Gukovsky I, Reyes CN, Vaquero EC, Gukovskaya AS, and Pandol SJ. Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 284: G85-G95, 2003.
17. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NFkappaB. J Biol Chem 274: 27891-27897, 1999.
18. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985.
19. Hoshino T, Nakamura H, Okamoto M, Kato S, Araya S, Nomiyama K, Oizumi K, Young HA, Aizawa H, and Yodoi J. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am J Respir Crit Care Med 168: 1075-1083, 2003.
20. Kimura Y, Hirota M, Okabe A, Inoue K, Kuwata K, Ohmuraya M, and Ogawa M. Dynamic aspects of granulocyte activation in rat severe acute pancreatitis. Pancreas 27: 127-132, 2003.
21. Kondo N, Ishii Y, Kwon YW, Tanito M, Horita H, Nishinaka Y, Nakamura H, and Yodoi J. Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol 172: 442-448, 2004.
22. Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today 6: 441-448, 2000.
23. Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, and Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 178: 179-185, 1996.
24. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, and Hay RT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20: 3821-3830, 1992.
25. Mukaida N, Ishikawa Y, Ikeda N, Fujioka N, Watanabe S, Kuno K, and Matsushima K. Novel insight into molecular mechanism of endotoxin shock: biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-kappaB and regulation of cytokine production/action through beta2 integrin in vivo. J Leukoc Biol 59: 145-151, 1996.
26. Nakamura H, Matsuda M, Furuke K, Kitaoka Y, Iwata S, Toda K, Inamoto T, Yamaoka Y, Ozawa K, and Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett 42: 75-80, 1994.
27. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997.
28. Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, and Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci USA 98: 15143-15148, 2001.
29. Nakamura H. Thioredoxin as a key molecule in redox signaling. Antioxid Redox Signal 6: 15-17, 2004.
30. Naumann M and Scheidereit C. Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J 13: 4597-4607, 1994.
31. Neuschwander-Tetri BA, Ferrell LD, Sukhabote RJ, and Grendell JH. Glutathione monoethyl ester ameliorates caerulein-induced pancreatitis in the mouse. J Clin Invest 89: 109-116, 1992.
32. Nonn L, Williams RR, Erickson RP, and Powis G. The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol Cell Biol 23: 916-922, 2003.
33. Okubo K, Kosaka S, Isowa N, Hirata T, Hitomi S, Yodoi J, Nakano M, and Wada H. Amelioration of ischemia-reperfusion injury by human thioredoxin in rabbit lung. J Thorac Cardiovasc Surg 113: 1-9, 1997.
34. Perides G, Sharma A, Gopal A, Tao X, Dwyer K, Ligon B, and Steer ML. Secretin differentially sensitizes rat pancreatic acini to the effects of supramaximal stimulation with caerulein. Am J Physiol Gastrointest Liver Physiol 289: G713-G721, 2005.
35. Runkel NS, Moody FG, Smith GS, Rodriguez LF, LaRocco MT, and Miller TA. The role of the gut in the development of sepsis in acute pancreatitis. J Surg Res 51: 18-23, 1991.
36. Sanfey H, Bulkley GB, and Cameron JL. The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg 200: 405-413, 1984.
37. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
38. Shah V, Lyford G, Gores G, and Farrugia G. Nitric oxide in gastrointestinal health and disease. Gastroenterology 126: 903-913, 2004.
39. Steinle AU, Weidenbach H, Wagner M, Adler G, and Schmid RM. NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterology 116: 420-430, 1999.
40. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, and Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8: 757-764, 1989.
41. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N, and Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA 96: 4131-4136, 1999.
42. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM Jr, Billiar TR, and Geller DA. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 273: 15148-15156, 1998.
43. Traenckner EB, Wilk S, and Baeuerle PA. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J 13: 5433-5441, 1994.
44. Uchida K, Okazaki K, Nishi T, Uose S, Nakase H, Ohana M, Matsushima Y, Omori K, and Chiba T. Experimental immune-mediated pancreatitis in neonatally thymectomized mice immunized with carbonic anhydrase II and lactoferrin. Lab Invest 82: 411-424, 2002.
45. Van Laethem JL, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, and Deviere J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 108: 1917-1922, 1995.
46. Victor VM, Rocha M, and De la Fuente M. N-acetylcysteine protects mice from lethal endotoxemia by regulating the redox state of immune cells. Free Radic Res 37: 919-929, 2003.
47. Wallace JL and Miller MJ. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 119: 512-520, 2000.
48. Wig JD, Kochhar R, Ray JD, Krishna Rao DV, Gupta NM, and Ganguly NK. Endotoxemia predicts outcome in acute pancreatitis. J Clin Gastroenterol 26: 121-124, 1998.
49. Williams JA, Korc M, and Dormer RL. Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. Am J Physiol 235: 517-524, 1978.
50. Wulczyn FG, Krappmann D, and Scheidereit C. The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation. J Mol Med 74: 749-769, 1996.
51. Yamauchi J, Shibuya K, Sunamura M, Arai K, Shimamura H, Motoi F, Takeda K, and Matsuno S. Cytokine modulation in acute pancreatitis. J Hepatobil Pancreat Surg 8: 195-203, 2001.
52. Yang BM, Demaine AG, and Kingsnorth A. Chemokines MCP-1 and RANTES in isolated rat pancreatic acinar cells treated with CCK and ethanol in vitro. Pancreas 21: 22-31, 2000.
53. Yokomise H, Fukuse T, Hirata T, Ohkubo K, Go T, Muro K, Yagi K, Inui K, Hitomi S, Mitsui A, Hirakawa T, Yodoi J, and Wada H. Effect of recombinant human adult T cell leukemia-derived factor on rat lung reperfusion injury. Respiration 61: 99-104, 1994.
54. Yu JH, Lim JW, Namkung W, Kim H, and Kim KH. Suppression of cerulein-induced cytokine expression by antioxidants in pancreatic acinar cells. Lab Invest 82: 1359-1368, 2002.